Suppr超能文献

草药在脑缺血中的治疗潜力。

Therapeutic potential of herbal drugs in cerebral ischemia.

作者信息

Gupta Y K, Briyal Seema, Gulati Anil

机构信息

Neuropharmacology Laboratory, Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.

出版信息

Indian J Physiol Pharmacol. 2010 Apr-Jun;54(2):99-122.

Abstract

Stroke is one of the most important causes of mortality and morbidity in the world. Prevention and effective treatment of stroke is of the utmost importance. Cerebral ischemia causes disturbances in a variety of cellular and molecular mechanisms, including oxidative phosphorylation, membrane function, neurotransmitter release, and free radical generation. It has been years since tissue-type plasminogen activator (t-PA) became the first medication approved by the FDA for the management of stroke, with limited success. Thrombolytic therapy is the most effective therapeutic strategy for the prevention of brain injury and reduction of mortality in patients with cerebral infarction. However, a combination of established thrombolytic therapy and effective neuronal protection therapy may have more beneficial effects for patients with cerebral infarction. Because clinical trials of pharmacological neuroprotective strategies in stroke have been disappointing, attention has turned towards approaches which include herbal drugs that can be used in limiting the neurological damage associated with stroke. Herbal drugs may be used as prophylactic treatment in patients with high risk of stroke. Herbals drugs have been described in ancient systems of medicine for the treatment of various ailments associated with stroke and have more recently been reported to be beneficial in treating stroke. However, the strength of evidence to support the use of these herbal drugs is unclear. This review focuses on putative mechanisms underlying the beneficial effects of herbal drugs in patients with stroke and on the possibility of herbal drugs to increase the therapeutic time window in patients with cerebral ischemia.

摘要

中风是全球最重要的致死和致残原因之一。预防和有效治疗中风至关重要。脑缺血会引发多种细胞和分子机制紊乱,包括氧化磷酸化、膜功能、神经递质释放以及自由基生成。自组织型纤溶酶原激活剂(t-PA)成为美国食品药品监督管理局(FDA)批准用于治疗中风的首款药物以来,多年过去了,但成效有限。溶栓治疗是预防脑损伤和降低脑梗死患者死亡率最有效的治疗策略。然而,将既定的溶栓治疗与有效的神经保护治疗相结合,可能对脑梗死患者产生更有益的效果。由于中风药理神经保护策略的临床试验令人失望,人们的注意力已转向包括草药在内的方法,这些草药可用于限制与中风相关的神经损伤。草药可用于中风高危患者的预防性治疗。在古代医学体系中就有关于草药治疗与中风相关各种疾病的记载,最近也有报道称草药对治疗中风有益。然而,支持使用这些草药的证据力度尚不清楚。本综述重点关注草药对中风患者有益作用的潜在机制,以及草药延长脑缺血患者治疗时间窗的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验